Table 1 ICD-related genes.

From: Immunogenic cell death signature predicts survival and reveals the role of VEGFA + Mast cells in lung adenocarcinoma

Gene

Description

Role

References

PDIA3

Promotes the uptake of dead cell-associated antigens

Active

5,6,8,44

HMGB1

Promotes the synthesis of pro-inflammatory factors including type I IFNs

Active

5,6,7,8,44

AGER

PRR of HMGB1

Active

6,7,8

TLR2

PRR of HMGB1

Active

6,8

TLR4

PRR of HMGB1

Active

5,6,7,8,44

MYD88

Part of TLR4 signaling systems

Active

7,8,44

LY96

Part of TLR5 signaling systems

Active

44

HSPA1A

Stimulates the uptake of dead cell-associated antigens

Active

5,6,7,8,44

HSP90AA1

Stimulates the uptake of dead cell-associated antigens

Active

5,6,7,8,44

ANXA1

Guides the final approach of APCs to dying cells

Active

5,6,7,8

FPR1

PRR of ANXA1

Active

5,6,7,8

P2RX7

Purinergic receptor

Active

5,6,7,8,44

P2RY2

Purinergic receptor

ACTIVE

5,6,7,8

NT5E

The ATP-degrading ectoenzyme

Inhibition

5,6,8,44

ENTPD1

The ATP-degrading ectoenzyme

Inhibition

5,6,7,8,44

EIF2S1

eIF2αphosphorylation correlates with CALR exposure and tumor infiltration by DCs and CTLs

Active

5,6,7,8

EIF2AK3

eIF2αphosphorylase

Active

5,6,7,44

CALR

Promotes the uptake of dead cell-associated antigens

Active

5,6,7,8,44

LRP1

PRR of CALR

Active

5,6,8

CD47

As anti-phagocytic signals that antagonize CALR

Inhibition

5,6,7,8

CASP8

ICD-associated exposure of CALR

Active

6,7,8

ERN1

ICD-associated exposure of CALR

Active

5

XBP1

ICD-associated exposure of CALR

Active

5

BCAP31

ICD-associated exposure of CALR

Active

6,7

BAX

ICD-associated exposure of CALR

Active

7,44

BAK1

ICD-associated exposure of CALR

Active

7

VAMP1

ICD-associated exposure of CALR

Active

6,7

SNAP25

ICD-associated exposure of CALR

Active

6,7

STC1

retaining CALR intracellularly

Inhibition

5

TLR3

PRR of RNA

Active

5,6,7,8

ATG5

Autophagy

Active

8,44

ATG7

Autophagy

Active

8

CXCL10

Stimulates T-cell recruitment

Active

5

CXCR3

CXCL10 receptor

Active

8,44

NLRP3

Mediate pro-inflammatory effects

Active

7,8,44

CASP1

Mediate pro-inflammatory effects

Active

44

IL1B

Mediate pro-inflammatory effects

Active

6,7,8,44

Il17a

Mediate pro-inflammatory effects

Active

7,8,44

Il17ra

Il17a receptor

Active

7,8,44

PIK3CA

Ablation compromised Chemotherapy-induced ICD and Hyp-PDT induced ICD

Active

44

IL6

High IL6 associated with enhanced ICD

Active

44

TNF

High TNF associated with enhanced ICD

Active

44

IL1R1

Ablation compromised ICD

Active

44

PRF1

Ablation compromised ICD

Active

44

FOXP3

Mediate immunosuppressive effects

Inhibition

44

CTLA4

Mediate immunosuppressive effects

Inhibition

5,6

IL10

Mediate immunosuppressive effects

Inhibition

5,6,44

CD4

Depletion of these cells compromised ICD

Active

44

CD8A

Depletion of these cells compromised ICD

Active

44

CD8B

Depletion of these cells compromised ICD

Active

44

CGAS

Generating type I interferons

Active

5,6,7

STING1

generating type I interferons

Active

5,7

IFNAR1

Type I IFNs receptor

Active

5,6,7,8,44

IFNAR2

Type I IFNs receptor

Active

5,6,7,8

Type I IFNs

Immunostimulatory

Active

 

IFNA1

 

Active

5,6,7,8,44

IFNA2

 

Active

5,6,7,8

IFNA4

 

Active

5,6,7,8

IFNA5

 

Active

5,6,7,8

IFNA6

 

Active

5,6,7,8

IFNA7

 

Active

5,6,7,8

IFNA8

 

Active

5,6,7,8

IFNA10

 

Active

5,6,7,8

IFNA13

 

Active

5,6,7,8

IFNA14

 

Active

5,6,7,8

IFNA16

 

Active

5,6,7,8

IFNA17

 

Active

5,6,7,8

IFNA21

 

Active

5,6,7,8

IFNB1

 

Active

5,6,7,8,44

IFNG

 

Active

44